Understanding OUR Cytokine-Based Immunotherapy Candidates Our commitment extends to advancing a robust portfolio of programs aimed toward increasing the horizons of cytokine-based immunotherapy, especially for cancers where therapy possibilities remain limited. Use the links below to learn a lot more about our portfolio of cytokine-based immunotherapy candidates. Check out https://financefeeds.com/shiba-inu-price-prediction-2025-will-shib-finally-reach-1/